Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Accelmed Partners LP | 10% Owner | 2024-07-15 | 230,573 | $3.14 | $724.00kBuy |
URI Geiger | Director | 2024-07-15 | 230,573 | $3.14 | $724.00kBuy |
Dolev Rafaeli | Chief Executive Officer | 2024-07-15 | 19,100 | $3.14 | $59.97kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Accelmed Growth Partners LP | 1,450.14% | 60,487,545 | $178.44M | Insider |
URI Geiger | 323.14% | 13,478,872 | $39.76M | Insider |
Accelmed Partners LP | 138.27% | 5,767,340 | $17.01M | Insider |
Bonanza Capital Ltd | 112.59% | 4,696,474 | $13.85M | Insider |
22nw LP | 84.31% | 3,516,898 | $10.37M | Insider |
Bonanza Master Fund Ltd | 75.79% | 3,161,400 | $9.33M | Insider |
Broadfin Capital LLC | 61.10% | 2,548,594 | $7.52M | Insider |
Broadfin Healthcare Master Fund Ltd | 24.17% | 1,008,297 | $2.97M | Insider |
Austin W. Greenhouse David M. Marxe | 18.26% | 761,726 | $2.25M | Insider |
Dan W. Lufkin | 18.06% | 753,398 | $2.22M | Insider |